Mark Heaney
Impact in
- Hematology top 1%
- Acute Myeloid Leukemia Research
- Genetics top 1%
- Myeloproliferative Neoplasms: Diagnosis and Treatment
- Chronic Lymphocytic Leukemia Research
Papers in
- Genetics 35
- Myeloproliferative Neoplasms: Diagnosis and Treatment 22
- Chronic Lymphocytic Leukemia Research 13
- Co-authors
- David W. Golde (15 shared papers)Owen A. O’Connor (6 shared papers)David A. Scheinberg (12 shared papers)Jeffrey R. Gardner (12 shared papers)William Kevin Kelly (2 shared papers)Paul A. Marks (2 shared papers)Lawrence B. Schwartz (2 shared papers)Victoria M. Richon (2 shared papers)
- Journals
- Blood (33 papers)Journal of Clinical Oncology (11 papers)Leukemia Research (4 papers)Proceedings of the National Academy of Sciences (2 papers)Journal of Clinical Investigation (2 papers)
- Partner nations
- United StatesCanadaUnited Kingdom
In The Last Decade
Mark Heaney
90 papers receiving 4.5k citations
Mark Heaney's Hit Papers
Peers
Comparison fields: 5 of 125
- Hematology 935
- Genetics 852
- Oncology 840
- Pathology and Forensic Medicine 532
- Immunology 602
Countries citing papers authored by Mark Heaney
This map shows the geographic impact of Mark Heaney's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Heaney with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Heaney more than expected).
Fields of papers citing papers by Mark Heaney
This network shows the impact of papers produced by Mark Heaney. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Heaney. The network helps show where Mark Heaney may publish in the future.
Co-authors
The 25 scholars most cited alongside Mark Heaney, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 91 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Phase I Study of an Oral Histone Deacetylase Inhibitor, Suberoylanilide Hydroxamic Acid, in Patients With Advanced Cancer Hit paper breakdown → | 2005 | 741 |
| 2 | 2014 | 367 | |
| 3 | 2005 | 345 | |
| 4 | 1999 | 320 | |
| 5 | 2006 | 216 | |
| 6 | 2010 | 215 | |
| 7 | 2003 | 172 | |
| 8 | 2008 | 170 | |
| 9 | 2010 | 159 | |
| 10 | 1998 | 149 | |
| 11 | 2006 | 121 | |
| 12 | 2008 | 119 | |
| 13 | 2008 | 91 | |
| 14 | 2004 | 89 | |
| 15 | 2020 | 85 | |
| 16 | 2004 | 84 | |
| 17 | 1995 | 59 | |
| 18 | 1994 | 57 | |
| 19 | 2010 | 55 | |
| 20 | 2008 | 54 |
About Mark Heaney
Mark Heaney is a scholar working on Genetics, Molecular Biology, Hematology, Immunology and Oncology, having authored 91 papers that have together received 4.6k indexed citations. Recurring topics across this work include Myeloproliferative Neoplasms: Diagnosis and Treatment (22 papers), Acute Myeloid Leukemia Research (16 papers), Chronic Myeloid Leukemia Treatments (15 papers), Chronic Lymphocytic Leukemia Research (13 papers), Immune Response and Inflammation (10 papers), Eosinophilic Disorders and Syndromes (9 papers), Immunotherapy and Immune Responses (8 papers) and Mast cells and histamine (6 papers). The work is most often cited by research in Hematology (935 citations), Genetics (852 citations), Oncology (840 citations), Pathology and Forensic Medicine (532 citations) and Immunology (602 citations). Mark Heaney has collaborated with scholars based in United States, Canada and United Kingdom. Frequent co-authors include David W. Golde, Owen A. O’Connor, David A. Scheinberg, Jeffrey R. Gardner, William Kevin Kelly, Paul A. Marks, Lawrence B. Schwartz, Victoria M. Richon, Joseph G. Jurcic and Howard I. Scher. Their work appears in journals such as Blood, Journal of Clinical Oncology, Leukemia Research, Proceedings of the National Academy of Sciences and Journal of Clinical Investigation.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.